JP2020536123A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020536123A5 JP2020536123A5 JP2020539683A JP2020539683A JP2020536123A5 JP 2020536123 A5 JP2020536123 A5 JP 2020536123A5 JP 2020539683 A JP2020539683 A JP 2020539683A JP 2020539683 A JP2020539683 A JP 2020539683A JP 2020536123 A5 JP2020536123 A5 JP 2020536123A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- clofazimine
- present
- micronized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023145739A JP2023171770A (ja) | 2017-10-02 | 2023-09-08 | クロファジミンの吸入可能な組成物およびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762566633P | 2017-10-02 | 2017-10-02 | |
| US62/566,633 | 2017-10-02 | ||
| PCT/US2018/053947 WO2019070693A1 (en) | 2017-10-02 | 2018-10-02 | COMPOSITION FOR INHALING CLOFAZIMINE AND METHODS OF USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023145739A Division JP2023171770A (ja) | 2017-10-02 | 2023-09-08 | クロファジミンの吸入可能な組成物およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020536123A JP2020536123A (ja) | 2020-12-10 |
| JP2020536123A5 true JP2020536123A5 (https=) | 2021-11-11 |
Family
ID=65995179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020539683A Pending JP2020536123A (ja) | 2017-10-02 | 2018-10-02 | クロファジミンの吸入可能な組成物およびその使用方法 |
| JP2023145739A Pending JP2023171770A (ja) | 2017-10-02 | 2023-09-08 | クロファジミンの吸入可能な組成物およびその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023145739A Pending JP2023171770A (ja) | 2017-10-02 | 2023-09-08 | クロファジミンの吸入可能な組成物およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20200297626A1 (https=) |
| EP (1) | EP3691646A4 (https=) |
| JP (2) | JP2020536123A (https=) |
| CN (1) | CN111212645A (https=) |
| AU (2) | AU2018345609A1 (https=) |
| BR (1) | BR112020006609A2 (https=) |
| CA (1) | CA3077421A1 (https=) |
| WO (1) | WO2019070693A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112279815A (zh) * | 2019-07-22 | 2021-01-29 | 中国食品药品检定研究院 | 一种氯法齐明盐类化合物及其制备方法和用途 |
| CN121221570A (zh) * | 2019-11-06 | 2025-12-30 | 曼金德公司 | 氯法齐明的组合物，含它们的组合，它们的制备方法，含它们的用途和治疗方法 |
| AU2021263580A1 (en) * | 2020-05-01 | 2022-11-24 | Mannkind Corporation | Clofazimine composition and method for the treatment or prophylaxis of viral infections |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| US20240299379A1 (en) * | 2021-06-01 | 2024-09-12 | Board Of Regents, The University Of Texas System | Compositions of clofazimine and amikacin for pulmonary administration in the treatment of respiratory diseases |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2627696B1 (fr) * | 1988-02-26 | 1991-09-13 | Fournier Innovation Synergie | Nouvelle forme galenique du fenofibrate |
| TW237386B (https=) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
| EP2168571B1 (en) * | 2000-11-30 | 2018-08-22 | Vectura Limited | Particles for use in a Pharmaceutical Composition |
| EP2200613B1 (en) * | 2007-09-21 | 2018-09-05 | The Johns Hopkins University | Phenazine derivatives and uses thereof |
| GB0803969D0 (en) * | 2008-03-04 | 2008-04-09 | Britannia Pharmaceuticals Ltd | Improved phospholipid and method for its production |
| CN107596518B (zh) * | 2012-02-29 | 2021-04-23 | 普马特里克斯营业公司 | 可吸入干粉剂 |
| KR101466616B1 (ko) * | 2012-10-11 | 2014-11-28 | 한미약품 주식회사 | 건조분말 흡입장치 |
| WO2016081825A1 (en) * | 2014-11-21 | 2016-05-26 | KamTek, Inc. | Methods and compositions for treating clostridium difficile associated disease |
| WO2016123530A1 (en) * | 2015-01-30 | 2016-08-04 | The Regents Of The University Of Michigan | Compositions and methods for delivering pharmaceutical agents |
| JP6773675B2 (ja) * | 2015-03-11 | 2020-10-21 | アレックザ ファーマシューティカルズ， インコーポレイテッド | サーマルエアゾール凝縮プロセスのためのエアウェイにおける帯電防止材の使用 |
| WO2016196401A1 (en) * | 2015-05-29 | 2016-12-08 | The Texas A&M University System | Antimicrobial and anti-inflammatory compositions |
| JP6953414B2 (ja) * | 2016-01-20 | 2021-10-27 | フラリー パウダーズ エルエルシーＦｌｕｒｒｙ Ｐｏｗｄｅｒｓ，Ｌｌｃ | 親油性成分を含む吸入に好適な分散性の噴霧乾燥粉末を製造する方法 |
-
2018
- 2018-10-02 CN CN201880064576.0A patent/CN111212645A/zh active Pending
- 2018-10-02 EP EP18863935.5A patent/EP3691646A4/en not_active Withdrawn
- 2018-10-02 WO PCT/US2018/053947 patent/WO2019070693A1/en not_active Ceased
- 2018-10-02 JP JP2020539683A patent/JP2020536123A/ja active Pending
- 2018-10-02 BR BR112020006609-5A patent/BR112020006609A2/pt not_active Application Discontinuation
- 2018-10-02 CA CA3077421A patent/CA3077421A1/en active Pending
- 2018-10-02 US US16/652,904 patent/US20200297626A1/en not_active Abandoned
- 2018-10-02 AU AU2018345609A patent/AU2018345609A1/en not_active Abandoned
-
2023
- 2023-08-30 US US18/458,258 patent/US20240099967A1/en active Pending
- 2023-09-08 JP JP2023145739A patent/JP2023171770A/ja active Pending
-
2024
- 2024-08-07 AU AU2024205572A patent/AU2024205572A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020536123A5 (https=) | ||
| JP5727927B2 (ja) | フルオロキノロンの肺送達 | |
| Das et al. | Inhaled dry powder formulations for treating tuberculosis | |
| US20240099967A1 (en) | Inhalable composition of clofazimine and methods of use thereof | |
| CA2838030A1 (en) | Combination comprising umeclidinium and a corticosteroid | |
| JP7654544B2 (ja) | ベダキリンの組成物、それらを含む組み合わせ、それらを調製するための方法、それらを含む使用及び治療方法 | |
| JP2024102268A (ja) | 乾燥粉末吸入製剤、および肺の治療的処置のためのその使用 | |
| JP2006514679A (ja) | トロスピウム含有組成物 | |
| CN1972730A (zh) | 格隆溴铵用于治疗儿童哮喘 | |
| CN112336703B (zh) | 一种用于治疗肺结核的异烟肼干粉吸入剂 | |
| JP6850524B2 (ja) | 吸入用の乾燥粉末製剤 | |
| WO2016176552A1 (en) | Dry power formulations for inhalation | |
| US20170348333A1 (en) | Dry powder formulations for inhalation | |
| JP2012524815A (ja) | 乾燥粉末吸引器において有用な凝集体配合物 | |
| JP2023524064A (ja) | ウイルス感染を治療又は予防するためのクロファジミン組成物及び方法 | |
| EP2931252A1 (en) | Combination of umeclidinium, fluticasone propionate and salmeterol xinafoate for use in the treatment of inflammatory or respiratory tract diseases | |
| CA3059824A1 (en) | A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic | |
| US20240299379A1 (en) | Compositions of clofazimine and amikacin for pulmonary administration in the treatment of respiratory diseases | |
| JP2011509936A5 (https=) | ||
| JPWO2019145897A5 (https=) | ||
| Das¹ et al. | Anti-Tubercular Drugs | |
| JP2025511232A (ja) | 吸入複合体及び担体ベースの製剤の組合せ | |
| CN120322221A (zh) | 用于吸入的包含糖和脂质复合颗粒的结晶药物组合物及其制备方法 | |
| CN114344285A (zh) | 改良的可吸入团聚物 | |
| CN107205958A (zh) | 包含福莫特罗和布地奈德的药物组合物 |